Neuro Clinical Decision Support Templates
Project Tracker
Created: January 15, 2026
Last Updated: January 30, 2026
Target: 150+ validated templates
Current Status: 102 templates approved
Legend
- ✅ = Completed and approved
- 🔄 = In progress / Under revision
- ⬜ = Not started
- 🎯 = Outpatient Priority (from outpatient product list)
OUTPATIENT PRODUCT PRIORITY LIST
These diagnoses are prioritized for the outpatient clinical tool. Items marked with ✅ already have approved plans.
Seizure & Epilepsy
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
New Onset Seizure |
R56.9 |
🎯 OPD |
Approved |
| ✅ |
Status Epilepticus |
G41.9 |
🎯 OPD |
Approved |
| ✅ |
Breakthrough Seizure (Known Epilepsy) |
G40.909 |
🎯 OPD |
Approved |
| ✅ |
Non-Convulsive Status Epilepticus (NCSE) |
G41.0 |
🎯 OPD |
Approved |
| ✅ |
Alcohol Withdrawal Seizure |
G40.509 |
🎯 OPD |
Approved |
| ⬜ |
Eclampsia/Seizure in Pregnancy |
O15.9 |
🎯 OPD |
Special ASM considerations |
| ⬜ |
Drug-Resistant Epilepsy |
G40.919 |
🎯 OPD |
Subspecialty referral focus |
| ⬜ |
Epilepsy Evaluation |
G40.909 |
🎯 OPD |
General workup |
Stroke & Cerebrovascular
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Acute Ischemic Stroke |
I63 |
🎯 OPD |
Approved |
| ✅ |
Intracerebral Hemorrhage (ICH) |
I61.9 |
🎯 OPD |
Approved |
| ✅ |
Subarachnoid Hemorrhage (SAH) |
I60.9 |
🎯 OPD |
Approved |
| ✅ |
Transient Ischemic Attack (TIA) |
G45.9 |
🎯 OPD |
Approved |
| ✅ |
Cerebral Venous Thrombosis (CVT) |
I67.6 |
🎯 OPD |
Approved |
| ✅ |
Carotid/Vertebral Dissection |
I77.71 |
🎯 OPD |
Approved |
| ✅ |
Posterior Reversible Encephalopathy (PRES) |
F93.49 |
🎯 OPD |
Approved |
| ✅ |
Reversible Cerebral Vasoconstriction (RCVS) |
I67.841 |
🎯 OPD |
Thunderclap headache DDx |
| ✅ |
CNS Vasculitis |
I67.7 |
🎯 OPD |
Rare, comprehensive workup |
| ⬜ |
Moyamoya Disease |
I67.5 |
🎯 OPD |
Rare |
| ⬜ |
Post-Stroke Management |
I69.30 |
🎯 OPD |
Secondary prevention |
| ⬜ |
Carotid Stenosis |
SI65.29 |
🎯 OPD |
Surgical evaluation |
Headache
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ⬜ |
Headache - Cluster Evaluation |
R51.9 |
🎯 OPD |
Broad DDx approach |
| ✅ |
Migraine (without Aura) |
G43.909 |
🎯 OPD |
Approved |
| ✅ |
Migraine with Aura |
G43.109 |
🎯 OPD |
Approved |
| ✅ |
Chronic Migraine |
G43.709 |
🎯 OPD |
Approved |
| ✅ |
Status Migrainosus |
G43.901 |
🎯 OPD |
Approved |
| ✅ |
Cluster Headache |
G44.009 |
🎯 OPD |
Approved |
| ✅ |
Tension-Type Headache |
G44.209 |
🎯 OPD |
Approved |
| ✅ |
Medication Overuse Headache |
G44.41 |
🎯 OPD |
Approved |
| ✅ |
Idiopathic Intracranial Hypertension (IIH) |
G93.2 |
🎯 OPD |
Approved |
| ✅ |
Low Pressure Headache / SIH |
G96.00 |
🎯 OPD |
Approved |
| ✅ |
Trigeminal Neuralgia |
G50.0 |
🎯 OPD |
Approved |
| ⬜ |
New Daily Persistent Headache |
G44.52 |
🎯 OPD |
Refractory cases |
| ⬜ |
Thunderclap Headache Evaluation |
R51.9 |
🎯 OPD |
SAH, RCVS, other emergencies |
| ✅ |
Giant Cell Arteritis (GCA) |
M31.6 |
🎯 OPD |
Approved |
Demyelinating Diseases
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
MS - New Diagnosis |
G35 |
🎯 OPD |
Approved |
| ✅ |
MS - Chronic Management |
G35 |
🎯 OPD |
Approved |
| ✅ |
Optic Neuritis |
H46.9 |
🎯 OPD |
Approved |
| ✅ |
Acute Myelopathy |
G95.9 |
🎯 OPD |
Approved (covers transverse myelitis) |
| ✅ |
Neuromyelitis Optica (NMOSD) |
G36.0 |
🎯 OPD |
Approved |
| ✅ |
MOG Antibody Disease (MOGAD) |
G36.9 |
🎯 OPD |
Approved |
| ⬜ |
Acute Disseminated Encephalomyelitis (ADEM) |
G04.81 |
🎯 OPD |
More common in pediatrics |
| ⬜ |
Progressive Multifocal Leukoencephalopathy (PML) |
A81.2 |
🎯 OPD |
JCV, immunocompromised |
| ⬜ |
Diffuse White Matter Disease |
R53.1 |
🎯 OPD |
Differential diagnosis |
Neuromuscular Disorders
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Guillain-Barre Syndrome (GBS) |
G61.0 |
🎯 OPD |
Approved |
| ✅ |
Myasthenia Gravis - Crisis |
G70.01 |
🎯 OPD |
Approved |
| ✅ |
Myasthenia Gravis - New Diagnosis |
G70.0 |
🎯 OPD |
Approved |
| ✅ |
Myasthenia Gravis - Outpatient |
G70.00 |
🎯 OPD |
Approved |
| ✅ |
Peripheral Neuropathy (General) |
G62.9 |
🎯 OPD |
Approved |
| ✅ |
CIDP (Chronic Inflammatory Demyelinating) |
G61.81 |
🎯 OPD |
Approved |
| ✅ |
Amyotrophic Lateral Sclerosis (ALS) |
G12.21 |
🎯 OPD |
Approved |
| ✅ |
Diabetic Neuropathy |
E11.42 |
🎯 OPD |
Approved |
| ✅ |
Small Fiber Neuropathy |
G62.9 |
🎯 OPD |
Approved |
| ✅ |
Carpal Tunnel Syndrome |
G56.00 |
🎯 OPD |
Approved |
| ✅ |
Radiculopathy |
M54.10 |
🎯 OPD |
Approved |
| ✅ |
Neuromuscular Respiratory Failure |
J96.00 |
🎯 OPD |
Approved |
| ✅ |
Lambert-Eaton Myasthenic Syndrome (LEMS) |
G73.1 |
🎯 OPD |
Approved |
| ✅ |
Inflammatory Myopathy (Dermatomyositis/PM) |
G72.41 |
🎯 OPD |
Approved |
| ✅ |
Inclusion Body Myositis (IBM) |
G72.41 |
🎯 OPD |
Approved |
| ⬜ |
Muscular Dystrophy (Adult) |
G71.0 |
🎯 OPD |
Rare adult presentations |
| ✅ |
Myotonic Dystrophy |
G71.11 |
🎯 OPD |
Approved |
| ✅ |
Critical Illness Myopathy/Neuropathy |
G72.81 |
🎯 OPD |
Approved |
| ⬜ |
Botulism |
A05.1 |
🎯 OPD |
Rare but critical |
| ✅ |
B12 Deficiency Neuropathy |
E53.8 |
🎯 OPD |
Approved |
| ⬜ |
Chemotherapy-Induced Neuropathy |
G62.0 |
🎯 OPD |
Growing population |
| ⬜ |
Ulnar Neuropathy |
G56.20 |
🎯 OPD |
Entrapment |
| ⬜ |
Peroneal Neuropathy |
F57.30 |
🎯 OPD |
Foot drop |
| ⬜ |
Multifocal Motor Neuropathy (MMN) |
G61.82 |
🎯 OPD |
GBS mimic |
| ⬜ |
Hereditary Neuropathy (CMT) |
G60.0 |
🎯 OPD |
Genetic |
| ⬜ |
Vasculitic Neuropathy |
G63 |
🎯 OPD |
Mononeuritis multiplex |
| ⬜ |
Autonomic Neuropathy |
G90.09 |
🎯 OPD |
Orthostatic, GI, cardiac |
| ⬜ |
Plexopathy |
G54.0 |
🎯 OPD |
Brachial/lumbosacral |
Movement Disorders
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Parkinson's Disease - New Diagnosis |
G20 |
🎯 OPD |
Approved |
| ✅ |
Parkinson's Disease - Management |
G20 |
🎯 OPD |
Approved |
| ⬜ |
Parkinson's Disease - Motor Fluctuations |
G20 |
🎯 OPD |
On/off, dyskinesia |
| ⬜ |
Parkinson's Disease - Psychosis |
F06.0 |
🎯 OPD |
Common, management |
| ✅ |
Essential Tremor |
G25.0 |
🎯 OPD |
Approved |
| ✅ |
Dystonia |
G24.9 |
🎯 OPD |
Approved |
| ✅ |
Huntington's Disease |
G10 |
🎯 OPD |
Approved |
| ✅ |
Tardive Dyskinesia |
G24.01 |
🎯 OPD |
Approved |
| ✅ |
Restless Legs Syndrome |
G25.81 |
🎯 OPD |
Approved |
| ✅ |
Drug-Induced Parkinsonism |
G21.11 |
🎯 OPD |
Approved |
| ✅ |
Wilson's Disease |
E83.01 |
🎯 OPD |
Approved |
| ✅ |
Progressive Supranuclear Palsy (PSP) |
G23.1 |
🎯 OPD |
Approved |
| ✅ |
Multiple System Atrophy (MSA) |
G90.3 |
🎯 OPD |
Approved |
| ⬜ |
Corticobasal Degeneration (CBD) |
G31.85 |
🎯 OPD |
Rare |
| ⬜ |
Tics / Tourette Syndrome |
F95.2 |
🎯 OPD |
Tic disorders |
| ✅ |
Ataxia Evaluation |
R27.0 |
🎯 OPD |
Approved |
| ⬜ |
Chorea Evaluation |
G25.5 |
🎯 OPD |
DDx approach |
| ⬜ |
Gait Disorder Evaluation |
R26.9 |
🎯 OPD |
Multifactorial |
Dementia & Cognitive Disorders
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Dementia Evaluation (General) |
R41.81 |
🎯 OPD |
Approved |
| ✅ |
Alzheimer's Disease |
G30.9 |
🎯 OPD |
Approved |
| ✅ |
Vascular Dementia |
F01.50 |
🎯 OPD |
Approved |
| ✅ |
Lewy Body Dementia |
G31.83 |
🎯 OPD |
Approved |
| ✅ |
Frontotemporal Dementia |
G31.09 |
🎯 OPD |
Approved |
| ✅ |
Rapidly Progressive Dementia |
F03.90 |
🎯 OPD |
Approved |
| ✅ |
Normal Pressure Hydrocephalus (NPH) |
G91.2 |
🎯 OPD |
Approved |
| ✅ |
Mild Cognitive Impairment (MCI) |
G31.84 |
🎯 OPD |
Approved |
| ✅ |
Creutzfeldt-Jakob Disease (CJD) |
A81.00 |
🎯 OPD |
Approved |
| ⬜ |
Autoimmune Dementia/Encephalopathy |
G04.81 |
🎯 OPD |
Treatable |
| ⬜ |
Delirium vs Dementia |
R41.0 |
🎯 OPD |
Acute confusion workup |
| ⬜ |
Wernicke-Korsakoff Syndrome |
F10.96 |
🎯 OPD |
Thiamine deficiency |
CNS Infections
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Bacterial Meningitis |
G00.9 |
🎯 OPD |
Approved |
| ✅ |
HSV Encephalitis |
B00.4 |
🎯 OPD |
Approved |
| ✅ |
Autoimmune Encephalitis |
G04.81 |
🎯 OPD |
Approved |
| ✅ |
Epidural Abscess |
G06.1 |
🎯 OPD |
Approved |
| ✅ |
Viral Meningitis |
A87.9 |
🎯 OPD |
Supportive care focus |
| ✅ |
Fungal Meningitis |
G02 |
🎯 OPD |
Approved |
| ✅ |
TB Meningitis |
A17.0 |
🎯 OPD |
Approved |
| ⬜ |
Neurocysticercosis |
B69.0 |
🎯 OPD |
Endemic areas |
| ✅ |
Brain Abscess |
G06.0 |
🎯 OPD |
Neurosurgery consult |
| ⬜ |
HIV-Associated Neurocognitive Disorder |
B20 |
🎯 OPD |
AIDS dementia complex |
| ✅ |
Neurosyphilis |
A52.2 |
🎯 OPD |
Approved |
| ✅ |
Lyme Neuroborreliosis |
A69.22 |
🎯 OPD |
Approved |
Neuro-Oncology
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Brain Metastases |
C79.31 |
🎯 OPD |
Approved |
| ✅ |
Spinal Cord Compression (Malignant) |
G95.20 |
🎯 OPD |
Approved |
| ✅ |
Glioblastoma (GBM) |
C71.9 |
🎯 OPD |
Approved |
| ✅ |
Leptomeningeal Carcinomatosis |
C79.32 |
🎯 OPD |
Approved |
| ✅ |
Paraneoplastic Neurological Syndrome |
G13.0 |
🎯 OPD |
Antibody panels |
| ✅ |
Meningioma |
D32.9 |
🎯 OPD |
Approved |
| ✅ |
Primary CNS Lymphoma |
C85.19 |
🎯 OPD |
Approved |
| ⬜ |
Radiation-Induced Neurologic Injury |
G93.89 |
🎯 OPD |
Delayed complications |
| ⬜ |
Myelopathy (General) |
G99.2 |
🎯 OPD |
DDx approach |
Spinal Cord Disorders
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Cauda Equina Syndrome |
G83.4 |
🎯 OPD |
Approved |
| ✅ |
Cervical Myelopathy (Degenerative) |
M47.22 |
🎯 OPD |
Approved |
| ⬜ |
Lumbar Stenosis |
M48.06 |
🎯 OPD |
Common outpatient |
| ⬜ |
Syringomyelia |
G95.0 |
🎯 OPD |
Rare |
| ⬜ |
Subacute Combined Degeneration |
E53.8 |
🎯 OPD |
B12 deficiency |
Autoimmune & Inflammatory
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Neurosarcoidosis |
D86.82 |
🎯 OPD |
Approved |
| ⬜ |
Susac Syndrome |
H35.89 |
🎯 OPD |
Rare |
| ⬜ |
Neuro-Behcet's |
M35.2 |
🎯 OPD |
Rare |
| ✅ |
Stiff Person Syndrome |
G25.82 |
🎯 OPD |
Approved |
| ⬜ |
Hashimoto's Encephalopathy (SREAT) |
E06.3 |
🎯 OPD |
Diagnosis of exclusion |
Functional & Psychiatric
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Functional Neurological Disorder (FND) |
F44.9 |
🎯 OPD |
Approved |
| ✅ |
Psychogenic Non-Epileptic Spells (PNES) |
F44.4 |
🎯 OPD |
Approved |
| ⬜ |
Functional Movement Disorder |
F44.4 |
🎯 OPD |
Clinical signs |
| ⬜ |
Functional Cognitive Disorder |
F44.4 |
🎯 OPD |
DDx with dementia |
Neurocritical Care
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Elevated ICP Management |
G93.2 |
🎯 OPD |
Approved |
| ✅ |
Neuromuscular Respiratory Failure |
J96.00 |
🎯 OPD |
Approved |
| ✅ |
Brain Death Evaluation |
G93.82 |
🎯 OPD |
Approved |
| ✅ |
Anoxic Brain Injury / Prognostication |
G93.1 |
🎯 OPD |
Approved |
| ⬜ |
Hypertensive Encephalopathy |
I67.4 |
🎯 OPD |
BP management |
Other / Miscellaneous
| Status |
Diagnosis |
ICD-10 |
Priority |
Notes |
| ✅ |
Syncope Evaluation (Neuro Perspective) |
R55 |
🎯 OPD |
Approved |
| ✅ |
Vertigo / Dizziness Evaluation |
R42 |
🎯 OPD |
Approved |
| ✅ |
Bell's Palsy |
G51.0 |
🎯 OPD |
Approved |
| ✅ |
Wernicke Encephalopathy |
E51.2 |
🎯 OPD |
Approved |
| ⬜ |
Horner Syndrome |
G90.2 |
🎯 OPD |
Localization |
| ⬜ |
Nystagmus Evaluation |
H55.00 |
🎯 OPD |
Central vs peripheral |
| ✅ |
Post-Concussion Syndrome |
F07.81 |
🎯 OPD |
Approved |
| ⬜ |
Traumatic Brain Injury (TBI) |
S06.9 |
🎯 OPD |
ED evaluation |
| ⬜ |
Chronic Traumatic Encephalopathy (CTE) |
G31.89 |
🎯 OPD |
Emerging area |
| ⬜ |
Sleep Apnea (Neurologic Aspects) |
G47.33 |
🎯 OPD |
Usually sleep medicine |
| ✅ |
Narcolepsy |
G47.419 |
🎯 OPD |
Approved |
| ⬜ |
Insomnia (Neurologic) |
G47.00 |
🎯 OPD |
Sleep medicine |
| ⬜ |
REM Sleep Behavior Disorder |
G47.52 |
🎯 OPD |
Often precedes PD |
| ⬜ |
Parasomnia |
G47.50 |
🎯 OPD |
Sleep medicine |
| ⬜ |
Tinnitus Evaluation |
H93.19 |
🎯 OPD |
Neuro perspective |
STATISTICS
| Category |
Approved |
To Build |
Total |
| Seizure/Epilepsy |
5 |
3 |
8 |
| Stroke/Cerebrovascular |
9 |
3 |
12 |
| Headache |
12 |
2 |
14 |
| Demyelinating |
6 |
3 |
9 |
| Neuromuscular |
17 |
11 |
28 |
| Movement Disorders |
12 |
6 |
18 |
| Dementia/Cognitive |
9 |
3 |
12 |
| CNS Infections |
10 |
2 |
12 |
| Neuro-oncology |
7 |
2 |
9 |
| Spinal Cord |
2 |
3 |
5 |
| Autoimmune/Inflammatory |
2 |
3 |
5 |
| Functional/Psychiatric |
2 |
2 |
4 |
| Neurocritical Care |
4 |
1 |
5 |
| Other/Miscellaneous |
6 |
9 |
15 |
| TOTAL |
103 |
53 |
156 |
Note: 103 approved diagnoses map to 102 unique plan files (Parkinson's Disease has separate Management and New Diagnosis plans in a single file pair).
APPROVED PLANS
| # |
Diagnosis |
Version |
Approved Date |
| 1 |
New Onset Seizure |
v1.0 |
Jan 20, 2026 |
| 2 |
Status Epilepticus |
v1.2 |
Jan 20, 2026 |
| 3 |
MS - New Diagnosis |
v1.0 |
Jan 20, 2026 |
| 4 |
Peripheral Neuropathy |
v1.0 |
Jan 20, 2026 |
| 5 |
Acute Ischemic Stroke |
v1.2 |
Jan 21, 2026 |
| 6 |
Guillain-Barre Syndrome |
v1.1 |
Jan 26, 2026 |
| 7 |
Myasthenia Gravis - Crisis |
v1.1 |
Jan 26, 2026 |
| 8 |
Bacterial Meningitis |
v1.1 |
Jan 26, 2026 |
| 9 |
HSV Encephalitis |
v1.0 |
Jan 26, 2026 |
| 10 |
Autoimmune Encephalitis |
v1.0 |
Jan 26, 2026 |
| 11 |
Acute Myelopathy |
v1.1 |
Jan 27, 2026 |
| 12 |
Bell's Palsy |
v1.1 |
Jan 27, 2026 |
| 13 |
Brain Metastases |
v1.1 |
Jan 27, 2026 |
| 14 |
Breakthrough Seizure |
v1.1 |
Jan 27, 2026 |
| 15 |
Cauda Equina Syndrome |
v1.1 |
Jan 27, 2026 |
| 16 |
CIDP |
v1.1 |
Jan 27, 2026 |
| 17 |
Cluster Headache |
v1.1 |
Jan 27, 2026 |
| 18 |
Dementia Evaluation |
v1.1 |
Jan 27, 2026 |
| 19 |
Diabetic Neuropathy |
v1.1 |
Jan 27, 2026 |
| 20 |
Elevated ICP Management |
v1.1 |
Jan 27, 2026 |
| 21 |
Epidural Abscess |
v1.1 |
Jan 27, 2026 |
| 22 |
Essential Tremor |
v1.1 |
Jan 27, 2026 |
| 23 |
Idiopathic Intracranial Hypertension |
v1.1 |
Jan 27, 2026 |
| 24 |
Intracerebral Hemorrhage |
v1.1 |
Jan 27, 2026 |
| 25 |
Medication Overuse Headache |
v1.1 |
Jan 27, 2026 |
| 26 |
Migraine |
v1.1 |
Jan 27, 2026 |
| 27 |
MS - Chronic Management |
v1.1 |
Jan 27, 2026 |
| 28 |
Myasthenia Gravis - New Diagnosis |
v1.1 |
Jan 27, 2026 |
| 29 |
Neuromuscular Respiratory Failure |
v1.1 |
Jan 27, 2026 |
| 30 |
Parkinson's Disease |
v1.1 |
Jan 27, 2026 |
| 31 |
Rapidly Progressive Dementia |
v1.1 |
Jan 27, 2026 |
| 32 |
Restless Legs Syndrome |
v1.1 |
Jan 27, 2026 |
| 33 |
Spinal Cord Compression (Malignant) |
v1.1 |
Jan 27, 2026 |
| 34 |
Subarachnoid Hemorrhage |
v1.1 |
Jan 27, 2026 |
| 35 |
Syncope |
v1.1 |
Jan 27, 2026 |
| 36 |
Transient Ischemic Attack |
v1.1 |
Jan 27, 2026 |
| 37 |
Trigeminal Neuralgia |
v1.1 |
Jan 27, 2026 |
| 38 |
Vertigo/Dizziness Evaluation |
v1.1 |
Jan 27, 2026 |
| 39 |
Wernicke Encephalopathy |
v1.1 |
Jan 27, 2026 |
| 40 |
Parkinson's Disease - New Diagnosis |
v1.1 |
Jan 29, 2026 |
| 41 |
ALS |
v1.1 |
Jan 30, 2026 |
| 42 |
Alzheimer's Disease |
v1.1 |
Jan 30, 2026 |
| 43 |
Carpal Tunnel Syndrome |
v1.1 |
Jan 30, 2026 |
| 44 |
Dystonia |
v1.1 |
Jan 30, 2026 |
| 45 |
Frontotemporal Dementia |
v1.1 |
Jan 30, 2026 |
| 46 |
Huntington's Disease |
v1.1 |
Jan 30, 2026 |
| 47 |
Lewy Body Dementia |
v1.1 |
Jan 30, 2026 |
| 48 |
Migraine with Aura |
v1.1 |
Jan 30, 2026 |
| 49 |
Mild Cognitive Impairment |
v1.1 |
Jan 30, 2026 |
| 50 |
Myasthenia Gravis - Outpatient |
v1.1 |
Jan 30, 2026 |
| 51 |
Normal Pressure Hydrocephalus |
v1.1 |
Jan 30, 2026 |
| 52 |
Optic Neuritis |
v1.1 |
Jan 30, 2026 |
| 53 |
Radiculopathy |
v1.1 |
Jan 30, 2026 |
| 54 |
Small Fiber Neuropathy |
v1.1 |
Jan 30, 2026 |
| 55 |
Tardive Dyskinesia |
v1.1 |
Jan 30, 2026 |
| 56 |
Tension-Type Headache |
v1.1 |
Jan 30, 2026 |
| 57 |
Vascular Dementia |
v1.1 |
Jan 30, 2026 |
| 58 |
NMOSD |
v1.1 |
Jan 30, 2026 |
| 59 |
Cerebral Venous Thrombosis |
v1.1 |
Jan 30, 2026 |
| 60 |
Giant Cell Arteritis |
v1.1 |
Jan 30, 2026 |
| 61 |
Functional Neurological Disorder |
v1.1 |
Jan 30, 2026 |
| 62 |
Non-Convulsive Status Epilepticus |
v1.1 |
Jan 30, 2026 |
| 63 |
Chronic Migraine |
v1.1 |
Jan 30, 2026 |
| 64 |
Low Pressure Headache / SIH |
v1.1 |
Jan 30, 2026 |
| 65 |
Post-Concussion Syndrome |
v1.1 |
Jan 30, 2026 |
| 66 |
Drug-Induced Parkinsonism |
v1.1 |
Jan 30, 2026 |
| 67 |
Wilson's Disease |
v1.1 |
Jan 30, 2026 |
| 68 |
Progressive Supranuclear Palsy |
v1.1 |
Jan 30, 2026 |
| 69 |
Multiple System Atrophy |
v1.1 |
Jan 30, 2026 |
| 70 |
Lambert-Eaton Syndrome |
v1.1 |
Jan 30, 2026 |
| 71 |
Neurosarcoidosis |
v1.1 |
Jan 30, 2026 |
| 72 |
Glioblastoma |
v1.1 |
Jan 30, 2026 |
| 73 |
Cervical Artery Dissection |
v1.1 |
Jan 30, 2026 |
| 74 |
PRES |
v1.1 |
Jan 30, 2026 |
| 75 |
Creutzfeldt-Jakob Disease |
v1.1 |
Jan 30, 2026 |
| 76 |
Brain Death Evaluation |
v1.1 |
Jan 30, 2026 |
| 77 |
Leptomeningeal Carcinomatosis |
v1.1 |
Jan 30, 2026 |
| 78 |
RCVS |
v1.1 |
Jan 30, 2026 |
| 79 |
CNS Vasculitis (PACNS) |
v1.1 |
Jan 30, 2026 |
| 80 |
Viral Meningitis |
v1.1 |
Jan 30, 2026 |
| 81 |
Brain Abscess |
v1.1 |
Jan 30, 2026 |
| 82 |
Paraneoplastic Neurological Syndrome |
v1.1 |
Jan 30, 2026 |
| 83 |
Fungal Meningitis |
v1.1 |
Jan 30, 2026 |
| 84 |
Tuberculous Meningitis |
v1.1 |
Jan 30, 2026 |
| 85 |
MOGAD |
v1.1 |
Jan 30, 2026 |
| 86 |
Critical Illness Myopathy/Neuropathy |
v1.1 |
Jan 30, 2026 |
| 87 |
Anoxic Brain Injury |
v1.1 |
Jan 30, 2026 |
| 88 |
Alcohol Withdrawal Seizure |
v1.1 |
Jan 30, 2026 |
| 89 |
Status Migrainosus |
v1.1 |
Jan 30, 2026 |
| 90 |
Inflammatory Myopathy (DM/PM) |
v1.1 |
Jan 30, 2026 |
| 91 |
B12 Deficiency Neuropathy |
v1.1 |
Jan 30, 2026 |
| 92 |
Neurosyphilis |
v1.1 |
Jan 30, 2026 |
| 93 |
Inclusion Body Myositis |
v1.1 |
Jan 30, 2026 |
| 94 |
Meningioma |
v1.1 |
Jan 30, 2026 |
| 95 |
Psychogenic Non-Epileptic Spells (PNES) |
v1.1 |
Jan 30, 2026 |
| 96 |
Lyme Neuroborreliosis |
v1.1 |
Jan 30, 2026 |
| 97 |
Stiff Person Syndrome |
v1.1 |
Jan 30, 2026 |
| 98 |
Myotonic Dystrophy |
v1.1 |
Jan 31, 2026 |
| 99 |
Narcolepsy |
v1.1 |
Jan 31, 2026 |
| 100 |
Ataxia Evaluation |
v1.1 |
Jan 31, 2026 |
| 101 |
Primary CNS Lymphoma |
v1.1 |
Jan 31, 2026 |
| 102 |
Cervical Spondylotic Myelopathy |
v1.1 |
Jan 31, 2026 |
NEXT PRIORITIES (Recommended Build Order)
All Tier 1 and Tier 2 items from the original roadmap are now complete. Updated priorities:
Tier 1: High-Impact Gaps
- NMOSD (Neuromyelitis Optica) - distinct from MS, high-impact treatment decisions
- Cerebral Venous Thrombosis (CVT) - often missed, time-sensitive
- Giant Cell Arteritis (GCA) - vision-threatening emergency
- Functional Neurological Disorder (FND) - high-volume, growing area
- Non-Convulsive Status Epilepticus (NCSE) - often missed diagnosis
Tier 2: Common Outpatient
- Chronic Migraine - preventive therapy, CGRP agents
- Low Pressure Headache / SIH - post-LP, spontaneous
- Post-Concussion Syndrome - common
- Drug-Induced Parkinsonism - reversible, common
- Wilson's Disease - must-not-miss in young movement disorder
Tier 3: Subspecialty / Rare
- Progressive Supranuclear Palsy (PSP)
- Multiple System Atrophy (MSA)
- Lambert-Eaton Myasthenic Syndrome (LEMS)
- Neurosarcoidosis
- Glioblastoma (GBM)
NOTES
- Templates follow neuro-builder SKILL v2.2 format
- All templates require neuro-checker validation (target 90%+)
- Physician review required before clinical deployment
- Outpatient product prioritizes conditions with OPD setting coverage
- ICD-10 codes from outpatient priority list included for billing integration
- TIA duplicate resolved Jan 30: canonical file is
transient-ischemic-attack.md
CHANGE LOG
January 30, 2026
- Major update: 57 approved plans (was 9)
- Marked 48 additional diagnoses as ✅ across all categories
- Removed TIA duplicate (tia.md), canonical is transient-ischemic-attack.md
- Added approved plans 11-57 to approved table
- Updated statistics: 58 approved diagnoses, 98 to build, 156 total
- Updated next priorities (Tiers 1-2 complete, new Tier 1-3)
- Added Epidural Abscess, Acute Myelopathy, MG variants to tracker
January 26, 2026
- Combined outpatient product priority list with existing tracker
- Added ICD-10 codes for all diagnoses
- Updated approved plans count: 9 total
- New diagnoses added from outpatient list: 19
- Total diagnoses in tracker: 153
January 21, 2026
- Acute Ischemic Stroke approved
January 20, 2026
- 4 plans approved: New Onset Seizure, Status Epilepticus, MS New Diagnosis, Peripheral Neuropathy
January 15, 2026
- Initial tracker created